305 related articles for article (PubMed ID: 10874052)
21. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
[TBL] [Abstract][Full Text] [Related]
22. The therapeutic efficacy of intravenous immunoglobulin in anti-neutrophilic cytoplasmic antibody-associated vasculitis: a meta-analysis.
Shimizu T; Morita T; Kumanogoh A
Rheumatology (Oxford); 2020 May; 59(5):959-967. PubMed ID: 31377800
[TBL] [Abstract][Full Text] [Related]
23. Off-trial evaluation of the B cell-targeting treatment in the refractory cases of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: long-term follow-up from a single centre.
Pullerits R; Ljevak M; Vikgren J; Bokarewa M
Scand J Immunol; 2012 Oct; 76(4):411-20. PubMed ID: 22823472
[TBL] [Abstract][Full Text] [Related]
24. Complexed plasma elastase as an in vivo marker for leukocyte activation in antineutrophil cytoplasmic antibody-associated vasculitis.
Haubitz M; Schulzeck P; Schellong S; Schulze M; Koch KM; Brunkhorst R
Arthritis Rheum; 1997 Sep; 40(9):1680-4. PubMed ID: 9324023
[TBL] [Abstract][Full Text] [Related]
25. ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis.
Nowack R; Grab I; Flores-Suarèz LF; Schnülle P; Yard B; van der Woude FJ
Nephrol Dial Transplant; 2001 Aug; 16(8):1631-7. PubMed ID: 11477166
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
27. Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two Patients.
Crickx E; Machelart I; Lazaro E; Kahn JE; Cohen-Aubart F; Martin T; Mania A; Hatron PY; Hayem G; Blanchard-Delaunay C; de Moreuil C; Le Guenno G; Vandergheynst F; Maurier F; Crestani B; Dhote R; Silva NM; Ollivier Y; Mehdaoui A; Godeau B; Mariette X; Cadranel J; Cohen P; Puéchal X; Le Jeunne C; Mouthon L; Guillevin L; Terrier B;
Arthritis Rheumatol; 2016 Mar; 68(3):702-12. PubMed ID: 26473632
[TBL] [Abstract][Full Text] [Related]
28. Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation.
Elmedhem A; Adu D; Savage CO
Nephrol Dial Transplant; 2003 May; 18(5):1001-4. PubMed ID: 12686678
[TBL] [Abstract][Full Text] [Related]
29. Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis.
Weidanz F; Day CJ; Hewins P; Savage CO; Harper L
Am J Kidney Dis; 2007 Jul; 50(1):36-46. PubMed ID: 17591523
[TBL] [Abstract][Full Text] [Related]
30. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
31. Granulomatosis with polyangiitis and intravenous immunoglobulins: a case series and review of the literature.
Guidelli GM; Tenti S; Pascarelli NA; Galeazzi M; Fioravanti A
Autoimmun Rev; 2015 Aug; 14(8):659-64. PubMed ID: 25816995
[TBL] [Abstract][Full Text] [Related]
32. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.
de Joode AAE; Sanders JSF; Puéchal X; Guillevin LP; Hiemstra TF; Flossmann O; Rasmussen N; Westman K; Jayne DR; Stegeman CA
Rheumatology (Oxford); 2017 Nov; 56(11):1894-1901. PubMed ID: 28977502
[TBL] [Abstract][Full Text] [Related]
33. Mycophenolate mofetil as maintenance therapy in patients with vasculitis and renal involvement.
Iatrou C; Zerbala S; Revela I; Spanou E; Marinaki S; Nakopoulou L; Boletis J
Clin Nephrol; 2009 Jul; 72(1):31-7. PubMed ID: 19640385
[TBL] [Abstract][Full Text] [Related]
34. [Vasculitis management: discovery of antineutrophil cytoplasmic antibodies (ANCA)].
Guillevin L
Presse Med; 2007 May; 36(5 Pt 2):843-4. PubMed ID: 17449373
[No Abstract] [Full Text] [Related]
35. [Clinical and pathological features of anti-neutrophil cytoplasm antibody associated systemic vasculitis in children].
Yu F; Zhao MH; Huang JP; Yao Y; Zou WZ; Zhang YK; Wang HY
Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):831-4. PubMed ID: 14728889
[TBL] [Abstract][Full Text] [Related]
36. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.
Martinez V; Cohen P; Pagnoux C; Vinzio S; Mahr A; Mouthon L; Sailler L; Delaunay C; Sadoun A; Guillevin L;
Arthritis Rheum; 2008 Jan; 58(1):308-17. PubMed ID: 18163506
[TBL] [Abstract][Full Text] [Related]
37. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of systemic necrotizing vasculitis].
Guillevin L
Rev Med Interne; 2002 Dec; 23 Suppl 5():554s-558s. PubMed ID: 12701249
[No Abstract] [Full Text] [Related]
39. Treatment of systemic vasculitis with pooled intravenous immunoglobulin.
Jayne DR; Davies MJ; Fox CJ; Black CM; Lockwood CM
Lancet; 1991 May; 337(8750):1137-9. PubMed ID: 1674023
[TBL] [Abstract][Full Text] [Related]
40. Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis.
Chen M; Wang F; Zhao MH
Rheumatology (Oxford); 2009 Apr; 48(4):355-8. PubMed ID: 19181656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
